• HOME
  • ABOUT US
    • OUR SERVICES
    • ADVISORY BOARD
    • WHO WE ARE
    • THE MMAS
    • CASE STUDIES
    • RESEARCH AND PUBLICATIONS
    • NEWS
  • OUR PRODUCTS
    • ATLAS
    • BASE
    • MVMT
    • STRATA
    • EA
    • Codex
    • Expert
    • The Library
    • Zoe Adherence
  • Exchange
  • PARTNERSHIPS
    • OUR GLOBAL NETWORK
  • CONTACT US
  • LEGAL
  • More
    • HOME
    • ABOUT US
      • OUR SERVICES
      • ADVISORY BOARD
      • WHO WE ARE
      • THE MMAS
      • CASE STUDIES
      • RESEARCH AND PUBLICATIONS
      • NEWS
    • OUR PRODUCTS
      • ATLAS
      • BASE
      • MVMT
      • STRATA
      • EA
      • Codex
      • Expert
      • The Library
      • Zoe Adherence
    • Exchange
    • PARTNERSHIPS
      • OUR GLOBAL NETWORK
    • CONTACT US
    • LEGAL
  • Sign In
  • Create Account

  • Bookings
  • My Account
  • Signed in as:

  • filler@godaddy.com


  • Bookings
  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • HOME
  • ABOUT US
    • OUR SERVICES
    • ADVISORY BOARD
    • WHO WE ARE
    • THE MMAS
    • CASE STUDIES
    • RESEARCH AND PUBLICATIONS
    • NEWS
  • OUR PRODUCTS
    • ATLAS
    • BASE
    • MVMT
    • STRATA
    • EA
    • Codex
    • Expert
    • The Library
    • Zoe Adherence
  • Exchange
  • PARTNERSHIPS
    • OUR GLOBAL NETWORK
  • CONTACT US
  • LEGAL

Account


  • Bookings
  • My Account
  • Sign out


  • Sign In
  • Bookings
  • My Account

MVMT™: Measurable Variance Minimal Term

 

Introduction

MVMT™ ( Measurable Variance Minimal Term ) was developed to fill a critical gap in adherence measurement: the lack of a behaviorally anchored, time-specific instrument that captures a patient’s actual medication-taking behavior over a defined recent period. Existing scales often rely on present-tense, perception-based items, which can introduce recall bias, optimism bias, and psychometric inconsistencies. MVMT addresses these limitations by focusing on concrete behavior over the past week, providing a precise “snapshot” of adherence.


Where BASE™ measures predictive stability—the “video” of where a patient is heading—MVMT™ captures retrospective reality, the “still photograph” of what has already occurred. Together, these tools form a dual-lens system that grounds adherence assessment in both predictive modeling and lived behavioral evidence.


Methodology & Conceptual Foundation

Behavioral science shows that past behavior is the best predictor of future behavior. To ensure validity, MVMT items are:


  • Specific and time-anchored: All questions refer to the past seven days.
     
  • Behaviorally observable: Avoid vague phrasing such as “sometimes” or “ever” to reduce psychometric noise.
     
  • Domain-distinct: Each item measures a unique adherence domain, maximizing clarity and internal consistency.
     
  • Intentional vs. unintentional: MVMT differentiates intentional lapses from those due to forgetfulness or logistical barriers, enabling tailored intervention.
     
  • Paired with BASE™: Each MVMT item conceptually aligns with a BASE item to create a complementary system: BASE anticipates stability, MVMT verifies actual behavior.
     

Before You Begin

This is not a test. There are no right or wrong answers. Everyone manages medications differently. These assessments are designed to understand patient experiences, identify patterns, and guide supportive care. Responses are confidential.


Scoring for each item:


  • No = 1.0
     
  • Yes, once = 0.5
     
  • Yes, more than once = 0.0
     

Answer each question as honestly as possible, reflecting your recent experiences.


MVMT™ Questions

  1. Routine — In the past 7 days, did you have trouble taking your medication at the same time each day?
    ☐ No ☐ Yes, once ☐ Yes, more than once
     
  2. Memory — In the past 7 days, did you miss any doses?
    ☐ No ☐ Yes, once ☐ Yes, more than once
     
  3. Symptom Response — In the past 7 days, did you skip or stop taking medication because you felt better?
    ☐ No ☐ Yes, once ☐ Yes, more than once
     
  4. Side-Effects Response — In the past 7 days, did you stop or skip medication because of side effects?
    ☐ No ☐ Yes, once ☐ Yes, more than once
     
  5. Environment — In the past 7 days, did travel or changes in your environment cause you to miss medication?
    ☐ No ☐ Yes, once ☐ Yes, more than once
     
  6. Flexibility — In the past 7 days, did you have difficulty adjusting your routine to take medication when your schedule changed?
    ☐ No ☐ Yes, once ☐ Yes, more than once
     
  7. Integration — In the past 7 days, did taking medication feel like a hassle or not fit naturally into daily life?
    ☐ No ☐ Yes, once ☐ Yes, more than once
     

Intentional Non-Adherence Items: Q3 (Symptom Response) and Q4 (Side-Effects Response)


Behavioral Descriptors


MVMT_norm          Raw Score (0–7)          Descriptor                    Interpretation

0.00–0.25                  0–1.75                              Highly Prone              Adherence very limited

0.26–0.50                  2–3.5                                 Unstable                       Multiple lapses, inconsistent behavior

0.51–0.75                  3.5–5.25                         Moderately Steady Mostly adherent, occasional lapses

0.76–1.00                  5.25–7                             Reliable                          Strong adherence, few or no lapses 


MVMT provides a concrete behavioral snapshot, capturing real-time adherence and enabling the calculation of behavioral fragility metrics in conjunction with BASE and STRATA. By distinguishing between intentional and unintentional lapses, the instrument provides actionable insights for clinicians, supporting tailored interventions.


Analogy:


  • BASE = video of where the patient is going
     
  • MVMT = snapshot of where the patient has been
     
  • Together → a geometric, actionable map of behavioral fragility
     

Intellectual Property

MVMT™ is the intellectual property of Philip Morisky and is exclusively distributed through Adherence Cartography. Unauthorized use, reproduction, or distribution is strictly prohibited.

Exploratory and Hypothesis Generating

 Disclaimer on Use of the BSA Instrument

The BSA (Behavioral Stability Assessment) is an exploratory, hypothesis-generating research instrument. It is currently not a validated clinical tool and should not be used as the sole basis for diagnosis, treatment decisions, or patient care planning. 


Preliminary findings have provided favorable insights into its potential utility, but further validation studies are required to establish its reliability, validity, and clinical applicability. Any use of the BSA at this stage should be considered investigational and for research purposes only.


 

 

Copyright © 2023 Adherence. All Rights Reserved.
Adherence Cartography™, Behavioral Stability Assessment (BSA™,), Behavioral Adherence Score (BAS™), and Behavioral Stability Index (BSI™) are trademarks of Adherence Cartography.

MMAS®, MMAS-4™, MMAS-8™, Morisky Medication Adherence Scale™, and Morisky Scale™ are registered trademarks or trademarks owned by Dr. Donald E. Morisky.


health tech, digital health, telehealth, healthcare innovation, medical technology, ehealth, health informatics, remote patient monitoring, mhealth, telemedicine, patient engagement, wearable health devices, health app, ai in healthcare, telehealth solutions, virtual care, health tech startups, connected health, population health management, healthcare analytics, personalized medicine 

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept

Partnering to Expand Adherence in Bhutan’s Health System

Join us in advancing a national movement toward cartographic behavioral science and precision-guided adherence care.

Your support helps bring the BASE™, MVMT™, and STRATA™ frameworks to Bhutan’s health system in partnership with the Ministry of Health. Together, we are building the foundation for a behaviorally intelligent health infrastructure, equipping clinicians and policymakers to map, measure, and strengthen real-world treatment stability.


Your contribution directly advances evidence-based care, empowering Bhutan to lead in the next generation of global adherence innovation.
[Donate Now] 

Learn more